Spero Therapeutics Inc (SPRO) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

SPRO rapporto: 64%

100%

SPRO supera 18 di 28 ultime stime

Data del prossimo reportNov 11, 2024

Stimato per Q3 24:$-0.47

Cambiamenti implicati per il Q2 24:+42.42%

Cambiamenti implicati per il Q3 23:-2450.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 5, 2024	$-0.33 / $-0.35	$0.02 / 5.71%
Q1 24	May 15, 2024	$-0.24 / $-0.07	$-0.17 / -242.86%
Q4 23	Mar 13, 2024	$0.96 / $-0.18	$1.14 / 633.33%
Q3 23	Nov 13, 2023	$0.02 / $-0.15	$0.17 / 113.33%
Q2 23	Aug 10, 2023	$-0.23 / $-0.29	$0.06 / 20.69%
Q1 23	May 11, 2023	$-0.25 / $-0.35	$0.1 / 28.57%
Q4 22	Mar 30, 2023	$0.55 / $-0.4	$0.95 / 237.5%
Q3 22	Nov 14, 2022	$-0.33 / $-0.34	$0.01 / 2.94%

Fornitori di Dati: Xignite Logo